Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Nora Yang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Lipidology|June 29, 2020
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemiaZoe White, Chady H Hakim, Marine Theret, et al.
Molecular Therapy. Methods & Clinical Development|September 22, 2017
A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular DystrophyChady H Hakim, Nalinda B Wasala, Xiufang Pan, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle DiseaseChady H Hakim, Nathalie Clément, Lakmini P Wasala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2019
AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult MiceMichael E Nance, Ruicheng Shi, Chady H Hakim, et al.
British Journal of Pharmacology|September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidismVenkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
JCI Insight|December 7, 2018
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceChady H Hakim, Nalinda B Wasala, Christopher E Nelson, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Lipidology|June 29, 2020
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemiaZoe White, Chady H Hakim, Marine Theret, et al.
Molecular Therapy. Methods & Clinical Development|September 22, 2017
A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular DystrophyChady H Hakim, Nalinda B Wasala, Xiufang Pan, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle DiseaseChady H Hakim, Nathalie Clément, Lakmini P Wasala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2019
AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult MiceMichael E Nance, Ruicheng Shi, Chady H Hakim, et al.
British Journal of Pharmacology|September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidismVenkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
JCI Insight|December 7, 2018
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceChady H Hakim, Nalinda B Wasala, Christopher E Nelson, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 2